Go to main content

GC Pharma

NEWS

리스트 검색 입력 폼
전자공고 리스트 테이블 표
  Title Views

Announcement

2024. 04. 22

 GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024 72

Announcement

2024. 04. 22

 European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 67

Announcement

2024. 04. 22

 GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 38

Announcement

2024. 01. 11

 GC Biopharma’s groundbreaking for the plasma fractionation plant in Indonesia 1593

Announcement

2024. 01. 11

 GC Biopharma establishes mRNA production facility in Hwasun, Korea 1139

Announcement

2023. 11. 08

 The World’s First “Recombinant Anthrax Vaccine”: GC Biopharma applies for MFDS Approval 1185

Announcement

2023. 10. 11

 FDA Grants Orphan Drug Designation to GC Biopharma’s Drug Candidate for Thrombotic Thrombocytopenic Purpura 1203

Announcement

2023. 10. 11

 GC Biopharma to organize “Donate Blood with Love”, a healthy way of giving back to the community 596

Announcement

2023. 10. 11

 GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 325

Announcement

2023. 08. 16

 GC Biopharma Celebrates ‘World Hemophilia Day’ 46
처음으로이전 10개

12345

다음 10개끝으로